Impact of Mitochondrial A3243G Heteroplasmy on Mitochondrial Bioenergetics and Dynamics of Directly Reprogrammed MELAS Neurons

• Published in: Cells (Basel, Switzerland) Switzerland), 2022-12, Vol.12 (1), p.15
• Main Authors: Lin, Dar-Shong, Huang, Yu-Wen, Ho, Che-Sheng, Huang, Tung-Sun, Lee, Tsung-Han, Wu, Tsu-Yen, Huang, Zon-Darr, Wang, Tuan-Jen
• Format: Article
• Language: English
• Subjects: Age; Aged; Aging; Axonogenesis; Bioenergetics; Care and treatment; Dendritic branching; Dendritic spines; Diagnosis; DNA, Mitochondrial - genetics; Electron transport; Energy Metabolism - genetics; Fibroblasts; Gene mutations; Genetic aspects; Genetic testing; Health aspects; Heteroplasmy; Humans; induced neurons; Life sciences; MELAS; MELAS syndrome; MELAS Syndrome - genetics; Membrane potential; Mitochondria; Mitochondria - metabolism; Mitochondrial diseases; Mitochondrial DNA; Mutation; Neurodegenerative diseases; Neurogenesis; Neurologic manifestations of general diseases; Neurons; Oxidative phosphorylation; OXPHOS; Pathophysiology; Proteins; Reagents; Skin
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells12010015

The MELAS syndrome primarily affecting the CNS is mainly caused by the m.A3243G mutation. The heteroplasmy in different tissues affects the phenotypic spectrum, yet the impact of various levels of m.A3243G heteroplasmy on CNS remains elusive due to the lack of a proper neuronal model harboring m.A3243G mutation. We generated induced neurons (iNs) through the direct reprogramming of MELAS patients, with derived fibroblasts harboring high (>95%), intermediate (68%), and low (20%) m.A3243G mutation. iNs demonstrated neuronal morphology with neurite outgrowth, branching, and dendritic spines. The heteroplasmy and deficiency of respiratory chain complexes were retained in MELAS iNs. High heteroplasmy elicited the elevation in ROS levels and the disruption of mitochondrial membrane potential. Furthermore, high and intermediate heteroplasmy led to the impairment of mitochondrial bioenergetics and a change in mitochondrial dynamics toward the fission and fragmentation of mitochondria, with a reduction in mitochondrial networks. Moreover, iNs derived from aged individuals manifested with mitochondrial fission. These results help us in understanding the impact of various heteroplasmic levels on mitochondrial bioenergetics and mitochondrial dynamics in neurons as the underlying pathomechanism of neurological manifestations of MELAS syndrome. Furthermore, these findings provide targets for further pharmacological approaches of mitochondrial diseases and validate iNs as a reliable platform for studies in neuronal aspects of aging, neurodegenerative disorders, and mitochondrial diseases.